Patient Assistance Programs
Hepatitis |
Parent |
Contact | |
Epivir HBV |
GSK |
||
Hepsera |
Gilead Advancing Access |
||
Entecavir |
BMS Patient Assistance Foundation |
||
Tyzeka |
Novartis Patient Assistance Now |
||
Viread |
Gilead Advancing Access |
||
Intron A |
Schering-Plough Cares |
||
Pegasys |
Roche Patient Assistance Program |
||
| Additional Resources | |||
| Free Medicine Foundation | 573-996-3333 |
| Merck Vaccine Assistance Program | 800-293-3881 |
| NeedyMeds.com | N/A |
| Partnership for Prescription Assistance | 888-477-2669 |
| Prescription Discount Program | 800-506-3725 |
| Rx Assist | 800-444-4106 |
| Together Rx Access | 888-477-2669 |
HBF Drug Watch
With promising new compounds in development for hepatitis B, there is great hope that a cure will be found in the near future.
Visit the HBF Drug Watch for a complete list of approved hepatitis B drugs and compounds in development, as well as ourlist of Hepatitis B Clinical Trials.
Page last modified December 21, 2011










